Stockreport

Why Bio-Rad Laboratories Is Overvalued: A Fundamental And DCF Analysis [Seeking Alpha]

Bio-Rad Laboratories, Inc. Class B  (BIO.B) 
PDF Follow Summary Bio-Rad is filing fewer patents year after year, which suggests that it is struggling to innovate and develop new products and services. The compan [Read more]